Neuroendocrine Neoplasms Associated with Germline Pathogenic Variants in the Homologous Recombination Pathway

被引:0
|
作者
Marta Szybowska
Ozgur Mete
Evan Weber
Josh Silver
Raymond H. Kim
机构
[1] University Health Network,Fred A. Litwin Family Center in Genetic Medicine
[2] University Health Network,Department of Laboratory Medicine and Pathobiology
[3] University of Toronto,Medical Genetics
[4] McGill University Health Centre,Department of Molecular Genetics
[5] University of Toronto,Division of Medical Oncology, Department of Medicine
[6] University of Toronto,Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Fred. A. Litwin Centre in Genetic Medicine
[7] University Health Network,undefined
[8] University of Toronto,undefined
来源
Endocrine Pathology | 2019年 / 30卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Neuroendocrine neoplasms (NENs) have been primarily associated with germline pathogenic variants in genes involved in chromatin remodeling (MEN1), cell cycle control (CDKN1B), PI3K/mTOR signaling (TSC1/2, PTEN) as well as pseudohypoxia (VHL, SDHx). Recent work has implicated various genes involved in DNA repair pathways in the pathophysiology of a subset of pancreatic neuroendocrine neoplasms, including BRCA2, via the homologous recombination pathway (HRD). To date, germline variants in other HRD pathway genes have not been described to contribute to NEN. PALB2, RAD51C, and BARD1 are additional tumor suppressor genes which also mediate repair of double stranded DNA breaks through the HRD pathway and are implicated in hereditary breast (PALB2; BARD1) and ovarian (RAD51C) cancer. Here we report three cases of NEN associated with germline pathogenic variants in PALB2 (pancreatic NEN), RAD51C (thymic NEN), and BARD1 (pancreaticoduodenal NEN) respectively, further linking the DNA repair pathway to NENs.
引用
收藏
页码:237 / 245
页数:8
相关论文
共 50 条
  • [41] Germline pathogenic variants in melanoma patients.
    Beitsch, Peter
    Wernecke, Chloe
    Bontempo, Kelly
    Bentley, Brenna
    Whitworth, Pat
    Patel, Rakesh
    CANCER RESEARCH, 2022, 82 (12)
  • [42] New pathogenic germline variants identified in mesothelioma
    Belcaid, Laila
    Bertelsen, Birgitte
    Wadt, Karin
    Tuxen, Ida
    Spanggaard, Iben
    Hojgaard, Martin
    Sorensen, Jens Benn
    Ravn, Jesper
    Lassen, Ulrik
    Nielsen, Finn Cilius
    Rohrberg, Kristoffer
    Yde, Christina Westmose
    LUNG CANCER, 2023, 179
  • [43] ctDNA pathogenic variants (PVs) in homologous recombination repair (HRR) genes in patients with metastatic CRPC.
    Jaeger, Ellen
    Ledet, Elisa Marie
    Moses, Marcus W.
    Manogue, Charlotte
    Lewis, Brian E.
    Layton, Jodi Lyn
    Barata, Pedro C.
    Sartor, Oliver A.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [44] Germline mutations in homologous recombination repair (HRR) pathway in a Chinese multi-cancer retrospective analysis
    Zhang, L.
    Yu, H.
    Wang, W.
    Wang, D.
    Yuan, H.
    Ma, T.
    ANNALS OF ONCOLOGY, 2021, 32 : S1242 - S1242
  • [45] Functional analyses of rare germline BRCA1 variants by transcriptional activation and homologous recombination repair assays
    Nicola Bassi
    Henrikke Nilsen Hovland
    Kashif Rasheed
    Elisabeth Jarhelle
    Nikara Pedersen
    Eunice Kabanyana Mchaina
    Sara Marie Engelsvold Bakkan
    Nina Iversen
    Hildegunn Høberg-Vetti
    Bjørn Ivar Haukanes
    Per Morten Knappskog
    Ingvild Aukrust
    Elisabet Ognedal
    Marijke Van Ghelue
    BMC Cancer, 23
  • [46] Tumor Genotyping and Homologous Recombination Repair Gene Variants in Patients With Epithelial Ovarian Cancer: Is Pathogenic Enough?
    Fountzilas, Elena
    Kotoula, Vassiliki
    Koliou, Georgia-Angeliki
    Liontos, Michalis
    Papadopoulou, Kyriaki
    Giannoulatou, Eleni
    Papanikolaou, Alexios
    Tikas, Ioannis
    Chrisafi, Sofia
    Mauri, Davide
    Chatzopoulos, Kyriakos
    Fostira, Florentia
    Pectasides, Dimitrios
    Oikonomopoulos, Georgios
    Aivazi, Dimitra
    Andrikopoulou, Angeliki
    Visvikis, Anastasios
    Aravantinos, Gerasimos
    Zagouri, Flora
    Fountzilas, George
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [47] Functional analyses of rare germline BRCA1 variants by transcriptional activation and homologous recombination repair assays
    Bassi, Nicola
    Hovland, Henrikke Nilsen
    Rasheed, Kashif
    Jarhelle, Elisabeth
    Pedersen, Nikara
    Mchaina, Eunice Kabanyana
    Bakkan, Sara Marie Engelsvold
    Iversen, Nina
    Hoberg-Vetti, Hildegunn
    Haukanes, Bjorn Ivar
    Knappskog, Per Morten
    Aukrust, Ingvild
    Ognedal, Elisabet
    Van Ghelue, Marijke
    BMC CANCER, 2023, 23 (01)
  • [48] Germline RAD51B variants confer susceptibility to breast and ovarian cancers deficient in homologous recombination
    Setton, Jeremy
    Selenica, Pier
    Mukherjee, Semanti
    Shah, Rachna
    Pecorari, Isabella
    McMillan, Biko
    Pei, Isaac X.
    Kemel, Yelena
    Ceyhan-Birsoy, Ozge
    Sheehan, Margaret
    Tkachuk, Kaitlyn
    Brown, David N.
    Zhang, Liying
    Cadoo, Karen
    Powell, Simon
    Weigelt, Britta
    Robson, Mark
    Riaz, Nadeem
    Offit, Kenneth
    Reis-Filho, Jorge S.
    Mandelker, Diana
    NPJ BREAST CANCER, 2021, 7 (01)
  • [49] Germline RAD51B variants confer susceptibility to breast and ovarian cancers deficient in homologous recombination
    Jeremy Setton
    Pier Selenica
    Semanti Mukherjee
    Rachna Shah
    Isabella Pecorari
    Biko McMillan
    Isaac X. Pei
    Yelena Kemel
    Ozge Ceyhan-Birsoy
    Margaret Sheehan
    Kaitlyn Tkachuk
    David N. Brown
    Liying Zhang
    Karen Cadoo
    Simon Powell
    Britta Weigelt
    Mark Robson
    Nadeem Riaz
    Kenneth Offit
    Jorge S. Reis-Filho
    Diana Mandelker
    npj Breast Cancer, 7
  • [50] Clinical outcome of patients with advanced triple negative breast cancer with germline and somatic variants in homologous recombination gene
    Stjepanovic, N.
    Kim, R. H.
    Wilson, M.
    Mandilaras, V.
    Berman, H.
    Amir, E.
    Cescon, D.
    Elser, C.
    Armel, S. Randall
    McCuaig, J.
    Volenik, A.
    Demsky, R.
    Chow, H.
    Misyura, M.
    Wang, L.
    Oza, A. M.
    Kamel-Reid, S.
    Stockley, T.
    Bedard, P. L.
    CANCER RESEARCH, 2017, 77